In April 2022 Melinta Therapeutics acquired the rights to Toprol-XL (metoprolol succinate) Extended Release Tablets from New American Therapeutics. Since that time, Melinta has been integrating Toprol XL into existing production, distribution, and selling channels. As a result, when filling prescriptions for Toprol XL, you, or your patient's pharmacy may receive a message stating that product is no longer available. All strengths of Toprol XL are available and the same Toprol XL branded product is continuing to be manufactured for Melinta under Melinta NDC numbers. To help facilitate continued access to this same Toprol XL, please reference the new NDC codes below and order numbers that you, or your patient's pharmacy will use to purchase product from their respective wholesalers.
Toprol XL 25mg 100-bottle count |
Toprol XL 50mg 100-bottle count |
Toprol XL 100mg 100-bottle count |
Toprol XL 200mg 100-bottle count |
|
11-digit NDC | 70842-0110-02 | 70842-0111-02 | 70842-0112-02 | 70842-0113-02 |
Cencora (AmerisourceBergen) | 10280920 | 10280729 | 10280902 | 10280901 |
Cardinal Health | 5856083 | 5856091 | 5856109 | 5856117 |
McKesson | 2832475 | 2832483 | 2832491 | 2832509 |
Anda | 333826 | 333827 | 333828 | 333829 |
Dakota Drug | 173344 | 445304 | 445312 | 445379 |
Morris Dickson | 292193 | 292227 | 292235 | 292243 |
NC Mutual Drug | 474338 | 474395 | 474320 | 474312 |
Smith Drug | 981464 | 981472 | 981480 | 981498 |
Value Drug | 248152 | 248154 | 248155 | 248156 |
If you have questions about Toprol-XL or metoprolol availability,
contact us at 1-844-MED-MLNT (+1 844-633-6568), option 3.
This website uses cookies to enhance the browsing experience. By continuing you give us permission to deploy cookies as per our privacy and cookies policy.
TOPROL-XL® (metoprolol succinate) is a beta-adrenergic blocker indicated for the treatment of:
Contraindications
Warnings and Precautions
Adverse Reactions
Most common adverse reactions: tiredness, dizziness, depression, shortness of breath, bradycardia, hypotension, diarrhea, pruritus, rash.
Drug Interactions
Use in Specific Populations
Hepatic Impairment: Consider initiating TOPROL-XL therapy at low doses and gradually increase dosage to optimize therapy, while monitoring closely for adverse events.
Click here for full Prescribing Information for TOPROL-XL.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
For medical inquiries or to report an adverse event, other safety related information,
or product complaints for a company product, please contact Medical Information:
medinfo@melinta.com | 1-844-MED-MLNT (1-844-633-6568) | https://www.melintamedicalinformation.com
This product information is intended for US health care professionals only.
TOPROL-XL® is a registered trademark of the AstraZeneca group of companies.
©2024 Melinta Therapeutics. All Rights Reserved. 02/2024 PP-TOP-US-0002
If you would like information regarding products from New American Theraputics , please email